tiprankstipranks
Advertisement
Advertisement

SCNI Stock Latest News

Scinai Immunotherapeutics Revises €12M FENG Bid and Extends PinCell Option Timeline
Company AnnouncementsScinai Immunotherapeutics Revises €12M FENG Bid and Extends PinCell Option Timeline
8d ago
6K
SCNI
Scinai Immunotherapeutics Faces Nasdaq Minimum Bid Price Deficiency, Given Until September to Regain Compliance
PremiumCompany Announcements
Scinai Immunotherapeutics Faces Nasdaq Minimum Bid Price Deficiency, Given Until September to Regain Compliance
12d ago
6K
SCNI
Scinai Immunotherapeutics highlights expanded CDMO platform
PremiumThe Fly
Scinai Immunotherapeutics highlights expanded CDMO platform
12d ago
SCNI
Scinai Immunotherapeutics signs second amendment to PinCell option agreement
PremiumThe Fly
Scinai Immunotherapeutics signs second amendment to PinCell option agreement
29d ago
SCNI
Scinai Wins Expanded Israel Innovation Authority Backing for Robotic Aseptic Platform
PremiumCompany Announcements
Scinai Wins Expanded Israel Innovation Authority Backing for Robotic Aseptic Platform
1M ago
6K
SCNI
Scinai Immunotherapeutics Buys Recipharm Israel Unit, Seals Strategic CDMO Pact
PremiumCompany AnnouncementsScinai Immunotherapeutics Buys Recipharm Israel Unit, Seals Strategic CDMO Pact
1M ago
6K
SCNI
Scinai Immunotherapeutics Shareholders Approve Share Increase, Equity Grants and Auditor at December 22 Meeting
Premium
Company Announcements
Scinai Immunotherapeutics Shareholders Approve Share Increase, Equity Grants and Auditor at December 22 Meeting
3M ago
6K
SCNI
Scinai Immunotherapeutics Reports Growth and Pipeline Progress
Premium
Company Announcements
Scinai Immunotherapeutics Reports Growth and Pipeline Progress
4M ago
SCNI
Scinai Immunotherapeutics Reports Nine-Month 2025 Results and Strategic Developments
PremiumCompany Announcements
Scinai Immunotherapeutics Reports Nine-Month 2025 Results and Strategic Developments
4M ago
6K
SCNI
Scinai Immunotherapeutics Announces December 2025 Shareholder Meeting
PremiumCompany Announcements
Scinai Immunotherapeutics Announces December 2025 Shareholder Meeting
5M ago
6K
SCNI
Scinai Immunotherapeutics Announces Board Changes and New Accounting Firm Amid Cost-Cutting Efforts
PremiumCompany Announcements
Scinai Immunotherapeutics Announces Board Changes and New Accounting Firm Amid Cost-Cutting Efforts
5M ago
6K
SCNI
Scinai Immunotherapeutics Secures Grant to Boost CDMO Capabilities
PremiumCompany Announcements
Scinai Immunotherapeutics Secures Grant to Boost CDMO Capabilities
6M ago
6K
SCNI
Scinai Immunotherapeutics awarded grant from Israel Innovation Authority
PremiumThe FlyScinai Immunotherapeutics awarded grant from Israel Innovation Authority
6M ago
SCNI
Scinai Immunotherapeutics to Appeal Rejected Grant for PC111 Development
Premium
Company Announcements
Scinai Immunotherapeutics to Appeal Rejected Grant for PC111 Development
6M ago
6K
SCNI
Scinai Immunotherapeutics Secures $15 Million Equity Purchase Agreement
Premium
Company Announcements
Scinai Immunotherapeutics Secures $15 Million Equity Purchase Agreement
7M ago
6K
SCNI
Scinai Immunotherapeutics Reports Strong CDMO Growth and Financial Results for H1 2025
PremiumCompany Announcements
Scinai Immunotherapeutics Reports Strong CDMO Growth and Financial Results for H1 2025
7M ago
6K
SCNI
Scinai Immunotherapeutics’ PC111 featured in peer-reviewed publication
PremiumThe Fly
Scinai Immunotherapeutics’ PC111 featured in peer-reviewed publication
8M ago
SCNI
Scinai Immunotherapeutics Announces New Funding and CDMO Growth Ahead of BIO 2025
PremiumCompany Announcements
Scinai Immunotherapeutics Announces New Funding and CDMO Growth Ahead of BIO 2025
10M ago
6K
SCNI
Scinai Immunotherapeutics Secures Italian Approval for Pincell Acquisition
PremiumCompany Announcements
Scinai Immunotherapeutics Secures Italian Approval for Pincell Acquisition
10M ago
6K
SCNI
Scinai Immunotherapeutics Faces Financial Challenges, Seeks Growth
PremiumCompany AnnouncementsScinai Immunotherapeutics Faces Financial Challenges, Seeks Growth
10M ago
SCNI
Scinai Immunotherapeutics Reports Strong CDMO Growth
Premium
Company Announcements
Scinai Immunotherapeutics Reports Strong CDMO Growth
10M ago
SCNI
Scinai Immunotherapeutics Reports Strong Q1 2025 CDMO Revenue Growth
Premium
Company Announcements
Scinai Immunotherapeutics Reports Strong Q1 2025 CDMO Revenue Growth
10M ago
6K
SCNI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >